BSPKOTCPharmaceutical PreparationsFiscal year ends December 31
Bespoke Extracts, Inc.
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 12, 2025
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $5.62K
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q3 FY2025 Ended Sep 30, 2025 | Nov 19, 2025 | Before market open | $467.95K | $-0.01 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Jul 7, 2025 | During market hours | $263.16K | – | – |
Company guidance
Outlook given with results on Nov 19, 2025, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Gross Margin | Fourth Quarter 2025 | 50% | New |
| Revenue | Fourth Quarter 2025 | $425.00K to $500.00K | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Bespoke Extracts filed with the SEC
PRESS RELEASE, DATED NOVEMBER 12, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED JUNE 30, 2025
Results of operations · EX-99.1 to Form 8-K
Bespoke Extracts, Inc. Receives Regulatory Approval
Other events · EX-99.1 to Form 8-K
Extracts to Expand its Colorado Business and Capabilities with Acquisition of Best Day Ever
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Building a Portfolio of Premium Cannabis and CBD Assets Wonderleaf Acquisition Update December 14, 2021
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Bespoke Extracts to Acquire Colorado Based Wonderleaf, LLC
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K